Evaluation of the efficiency of insulin degludec/insulin aspart therapy in controlling hyperglycemia and hypoglycemia in patients with type 2 diabetes mellitus: a real-life experience

Background Insulin degludec/insulin aspart (IDegAsp) is the first dual combination that acts separately (basal and prandial actions). Different insulin regimens can be switched to IDegAsp. Several studies have been conducted evaluating the effectiveness and safety of IDegAsp. The purpose of this rea...

Full description

Saved in:
Bibliographic Details
Published in:International journal of diabetes in developing countries 2023-08, Vol.43 (4), p.544-550
Main Authors: Semiz, Gökçen Güngör, Selimoğlu, İsmail, Arayici, Mehmet Emin, Yener, Serkan, Çömlekçi, Abdurrahman, Demir, Tevfik
Format: Article
Language:English
Subjects:
Diabetes
Diabetes mellitus (non-insulin dependent)
Family Medicine
General Practice
Health Administration
Hyperglycemia
Hypoglycemia
Insulin
Medicine
Medicine & Public Health
Metabolism
Original Article
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Insulin degludec/insulin aspart (IDegAsp) is the first dual combination that acts separately (basal and prandial actions). Different insulin regimens can be switched to IDegAsp. Several studies have been conducted evaluating the effectiveness and safety of IDegAsp. The purpose of this real-life study was to determine the effects of IDegAsp on metabolic control and hypoglycemia in patients who were switched from different insulin regimens to IDegAsp therapy. Methods We retrospectively analysed the data of 401 patients. Comorbid conditions, metabolic parameters, total insulin dose, injection frequency and hypoglycemia events were recorded. Baseline data were compared with post-IDegAsp data. Results Of the 401 patients, 208 were females and 193 were males, with a mean age of 64.8 ± 10.5 years. The number of injections per day and total insulin doses decreased significantly ( p  
ISSN:0973-3930
1998-3832
DOI:10.1007/s13410-022-01140-w